Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of May 21, 2026, IBO trades at $0.53 with a market cap of $58.04M and a P/E ratio of -1.52. IBO moved +4.03% today. Year to date, IBO is +3.30%; over the trailing twelve months it is -3.03%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading IBO stock inside the company?
Recent IBO insider activity includes Macko Todd D sold 43.40K, Macko Todd D sold 1.60K, Grady Jason sold 50.00K, DSS, INC. sold 45.40K, and DSS, INC. sold 45.40K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
IBO Key Metrics
Key financial metrics for IBO
Metric
Value
Price
$0.53
Market Cap
$58.04M
P/E Ratio
-1.52
EPS
$-0.38
Dividend Yield
0.00%
52-Week High
$6.17
52-Week Low
$0.36
Volume
839
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-11.87M
Gross Margin
0.00%
Recent IBO Insider Trades
Macko Todd D sold 43.40K (~$24.37K) on Mar 27, 2026.
Macko Todd D sold 1.60K (~$961.28) on Mar 25, 2026.
Grady Jason sold 50.00K (~$32.51K) on Mar 23, 2026.
IBO analyst coverage data. Average price target: $0.00.
Common questions about IBO
Who is trading IBO stock inside the company?
Recent IBO insider activity includes Macko Todd D sold 43.40K, Macko Todd D sold 1.60K, Grady Jason sold 50.00K, DSS, INC. sold 45.40K, and DSS, INC. sold 45.40K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IBO?
Yes. Rallies tracks IBO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IBO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBO. It does not provide personalized investment advice.
